Aussie Researchers Part Of Global Plan For Trials Of Lung-Cancer Drugs
This article was originally published in PharmAsia News
Australian scientists were part of international research that determined a genetic mutation blocked existing drugs for treating some of the toughest forms of cancer
You may also be interested in...
The pharma giants are joining forces to help the UK reach its ambitious target of testing 100,000 people a day for coronavirus by the end of April.
Angelini is looking to take its recently-acquired ThermaCare brand to the next level by establishing a direct base in Germany to market the product and through a new distribution deal with Norway's Navamedic.
BD and BioMedomics have released a new rapid point-of-care test that can detect antibodies in blood to confirm current or past exposure to COVID-19.